Fluidigm Corp. (NASDAQ:FLDM)’s share price rose 3% on Thursday . The company traded as high as $9.10 and last traded at $9.06, with a volume of 64,932 shares traded. The stock had previously closed at $8.80.

FLDM has been the topic of a number of research reports. Zacks Investment Research raised Fluidigm Corp. from a “hold” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Tuesday. Cantor Fitzgerald reaffirmed a “buy” rating and set a $13.00 target price on shares of Fluidigm Corp. in a research report on Thursday, June 2nd. Deutsche Bank AG initiated coverage on Fluidigm Corp. in a research report on Wednesday, June 1st. They set a “buy” rating on the stock. Mizuho lowered their target price on Fluidigm Corp. from $11.00 to $8.00 and set a “buy” rating on the stock in a research report on Thursday, May 5th. Finally, Leerink Swann lowered their target price on Fluidigm Corp. from $20.00 to $15.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 12th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $13.74.

The stock’s 50-day moving average price is $9.66 and its 200 day moving average price is $8.49. The firm’s market capitalization is $278.57 million.

Fluidigm Corp. (NASDAQ:FLDM) last issued its quarterly earnings data on Thursday, May 5th. The company reported ($0.40) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.53) by $0.13. The business earned $29 million during the quarter, compared to the consensus estimate of $26.95 million. During the same quarter in the prior year, the business posted ($0.25) earnings per share. Fluidigm Corp.’s quarterly revenue was up 8.6% compared to the same quarter last year. Analysts expect that Fluidigm Corp. will post ($2.23) earnings per share for the current fiscal year.

Several large investors have modified their holdings of the company. Columbia Wanger Asset Management LLC acquired a new stake in shares of Fluidigm Corp. during the fourth quarter worth $19,337,000. Neuberger Berman Group LLC boosted its position in Fluidigm Corp. by 38.1% in the fourth quarter. Neuberger Berman Group LLC now owns 572,319 shares of the company’s stock worth $6,187,000 after buying an additional 157,760 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in Fluidigm Corp. during the fourth quarter worth approximately $1,045,000.

Fluidigm Corporation creates, manufactures and market technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company also offers instruments and consumables to academic institutions, clinical laboratories, pharmaceutical, biotechnology and agricultural biotechnology (Ag-Bio) companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.